Sector ratings Charles River Laboratories International, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 03:55:00 2026-08-05 pm EDT			5-day change	1st Jan Change
260.22 ^USD	+11.15%		+10.36%	+29.90%

02:46pm	Top Midday Gainers	MT
11:41am	Charles River Laboratories International, Inc., Q2 2026 Earnings Call, Aug 05, 2026

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	11.28B		AA
LONZA GROUP AG	48B		AAA
REVOLUTION MEDICINES, INC.	41.13B	-	B	-	-
IQVIA HOLDINGS INC.	37.56B		AAA
BEONE MEDICINES AG	35.91B		-
CELLTRION, INC.	29.86B		A
ASCENDIS PHARMA A/S	16.12B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.05B		BBB
EUROFINS SCIENTIFIC SE	13.76B		AA
ICON PUBLIC LIMITED COMPANY	12.1B		AAA
BIO-TECHNE CORPORATION	11.23B		AA
ABIVAX	10.79B	-	BBB	-	-
APOGEE THERAPEUTICS, INC.	10.07B	-	B	-	-
PHARMARON BEIJING CO., LTD.	9.85B		AA
IONIS PHARMACEUTICALS, INC.	9.15B	-	A	-	-
QIAGEN N.V.	8.75B		AAA
PROTAGONIST THERAPEUTICS, INC.	8.73B		BB		-
PRAXIS PRECISION MEDICINES, INC.	8.64B	-	B	-	-
KYMERA THERAPEUTICS, INC.	8.59B	-	BBB	-	-
TEMPUS AI, INC.	8.49B		A		-
Average	17.8B		A
Weighted average by Cap.			A